RVP (Retractable Technologies) Debt-to-Equity : 0.02 (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Retractable Technologies Debt-to-Equity?

Retractable Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.33 Mil. Retractable Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.99 Mil. Retractable Technologies's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $83.46 Mil. Retractable Technologies's debt to equity for the quarter that ended in Sep. 2024 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Retractable Technologies's Debt-to-Equity or its related term are showing as below:

RVP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.11 Max: 0.14
Current: 0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Retractable Technologies was 0.14. The lowest was 0.02. And the median was 0.11.

RVP's Debt-to-Equity is ranked better than
91.94% of 695 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs RVP: 0.02

Retractable Technologies Debt-to-Equity Historical Data

The historical data trend for Retractable Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Debt-to-Equity Chart

Retractable Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.09

0.08

0.02

Retractable Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.02

Competitive Comparison of Retractable Technologies's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Retractable Technologies's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Retractable Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Retractable Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.304	+	1.234)	/	99.288
	=	0.02

Retractable Technologies's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.325	+	0.987)	/	83.458
	=	0.02

Retractable Technologies (AMEX:RVP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Retractable Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Retractable Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

511 Lobo Lane, Little Elm, TX, USA, 75068-5295

Website

https://www.retractable.com

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Executives

Thomas J Shaw	director, 10 percent owner, officer: President and CEO	511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard	10 percent owner	156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr	director	816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley	director	1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman	director, officer: Vice President of Sales	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii	director, officer: Chief Financial Officer	511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack	director	1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut	director	1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno	10 percent owner	777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August	10 percent owner	340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner	director, officer: Exec. VP, Eng & Prod.	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza	director	P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu	director	511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King	director	9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios	officer: Vice President/General Counsel	511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies Headlines

From GuruFocus

Is Retractable Technologies (RVP) Modestly Undervalued? A Comprehensive Analysis

By GuruFocus Research • 08-22-2023

Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares

By gurufocus • 03-16-2009